Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

3yrs ago Cannabis blunttruthlaw Views: 401

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

The USDA is allowing more comments on its new hemp rule.  The House voted to allow marijuana research.  We have an update on the Nebraska situation.  Illinois’ social equity program comes under fire, while Maryland’s program is cleared of bias.  And cannabis is falling from the sky in Israel.

usda hemp rule

Regular readers will doubtless recall the general unhappiness over the USDA’s hemp rule, published in October 2019.  The agency responded this week by reopening the comment period.  It now runs until October 8, 2020.

marijuana research

In other federal news, the Medical Marijuana Research Act of 2019 advanced out of the House Energy and Commerce Committee by unanimous voice vote this week.  The bill would facilitate production of marijuana for use by researchers and expressly forbids interference by the Department of Justice or the Attorney General.

nebraska

As we’ve reported before, Nebraska’s medical marijuana initiative has had a rocky road to the ballot.  The state’s Supreme Court heard oral arguments late last week on whether to allow the measure to proceed to the voters.  The court could rule any day, so look for more on this subject next week.

illinois

In other state news, Illinois’ social equity program faces accusations that it shut out the very people it exists to help.  The program grants those who live in an area disproportionately affected by cannabis laws in the past or have past convictions additional points on applications for business licenses.  Now a lawsuit has been filed that claims places in the lottery system that will distribute licenses have gone to well-connected insiders.

maryland

Illinois isn’t the only state answering questions about its licensing process.  Unsuccessful applicants in Maryland claimed the state’s process lacked transparency and was subject to undue influence.  An investigation recently found “no evidence of bias.”

and finally

Call it manna from heaven.  Bags of cannabis fell from a drone over Rabin Square in Tel Aviv last week.  Sponsored by a group supporting the legalization of recreational marijuana, this may be the first of many “deliveries,” as COVID limits in-person contact.  Keep watching the skies!

Stay safe and be well everyone – we’ll see you next week!


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.